The Object-Based and Process-Based Regulation of Genome Editing
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Article in Periodical |
| Magazine / Source | EUROPEAN JOURNAL OF HEALTH LAW |
| MU Faculty or unit | |
| Citation | |
| Web | https://brill.com/view/journals/ejhl/29/3-5/article-p484_8.xml |
| Doi | http://dx.doi.org/10.1163/15718093-BJA10078 |
| Keywords | Genome editing; Health Law; Health Services |
| Description | The article explores whether the broader regulatory framework applicable to the member states of the EU contains suitable tools to react to the rapid advances in science, especially as to the question of germline editing technologies. From the perspective of EU member states, the regulatory framework is fragmented between norms of international law, secondary EU law and national legislation. The rules and their interpretation are strongly influenced by the concept of precaution, which reflects the concern that there is not enough knowledge to assess the impact of genome editing technology on individuals, society and future populations. However, the argument of precaution loses its strength with every new scientific discovery. |